These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27017906)

  • 1. Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
    Hendrix JA; Bateman RJ; Brashear HR; Duggan C; Carrillo MC; Bain LJ; DeMattos R; Katz RG; Ostrowitzki S; Siemers E; Sperling R; Vitolo OV
    Alzheimers Dement; 2016 May; 12(5):623-30. PubMed ID: 27017906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building a roadmap for developing combination therapies for Alzheimer's disease.
    Perry D; Sperling R; Katz R; Berry D; Dilts D; Hanna D; Salloway S; Trojanowski JQ; Bountra C; Krams M; Luthman J; Potkin S; Gribkoff V; Temple R; Wang Y; Carrillo MC; Stephenson D; Snyder H; Liu E; Ware T; McKew J; Fields FO; Bain LJ; Bens C
    Expert Rev Neurother; 2015 Mar; 15(3):327-33. PubMed ID: 25708309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charting a path toward combination therapy for Alzheimer's disease.
    Stephenson D; Perry D; Bens C; Bain LJ; Berry D; Krams M; Sperling R; Dilts D; Luthman J; Hanna D; McKew J; Temple R; Fields FO; Salloway S; Katz R
    Expert Rev Neurother; 2015 Jan; 15(1):107-13. PubMed ID: 25540951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.
    Gauthier S; Alam J; Fillit H; Iwatsubo T; Liu-Seifert H; Sabbagh M; Salloway S; Sampaio C; Sims JR; Sperling B; Sperling R; Welsh-Bohmer KA; Touchon J; Vellas B; Aisen P
    J Prev Alzheimers Dis; 2019; 6(3):164-168. PubMed ID: 31062826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Novel Pharmaceutical Agents for Alzheimer's Disease: The Impact of Regulatory Initiatives in Japan and the United States.
    Tsukamoto K
    Clin Ther; 2015 Aug; 37(8):1652-60. PubMed ID: 25801940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting amyloid precursor protein secretases: Alzheimer's disease and beyond.
    Ganjei JK
    Drug News Perspect; 2010 Nov; 23(9):573-84. PubMed ID: 21152452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease drug development based on Computer-Aided Drug Design.
    Zeng H; Wu X
    Eur J Med Chem; 2016 Oct; 121():851-863. PubMed ID: 26415837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why did tarenflurbil fail in Alzheimer's disease?
    Imbimbo BP
    J Alzheimers Dis; 2009; 17(4):757-60. PubMed ID: 19542625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production and catabolism of amyloid peptides in Alzheimer's disease].
    Checler F
    Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease.
    Vardy ER; Catto AJ; Hooper NM
    Trends Mol Med; 2005 Oct; 11(10):464-72. PubMed ID: 16153892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of Golgi apparatus in Alzheimer's disease.
    Hu Z; Zeng L; Huang Z; Zhang J; Li T
    Neurochem Res; 2007 Aug; 32(8):1265-77. PubMed ID: 17401657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
    J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of aricept with a traditional Chinese medicine formula, smart soup, may be a novel way to treat Alzheimer's disease.
    Wang Y; Wang Y; Sui Y; Yu H; Shen X; Chen S; Pei G; Zhao J; Ding J
    J Alzheimers Dis; 2015; 45(4):1185-95. PubMed ID: 25690664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.